Climate change puts Lyme disease in focus for France's Valneva after COVID blow
With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.
Reuters ·